On 2025-05-06, Ginkgo Bioworks Holdings, Inc. (DNA) announced earnings per share of $-1.58 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.23.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-1.29 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-1.23 | $-1.58 |
| 2025-02-25 | 2024-12-31 | $-1.45 | $-1.82 |
| 2024-11-12 | 2024-09-30 | $-2.40 | $-1.08 |
| 2024-08-08 | 2024-06-30 | $-3.20 | $-3.20 |
| 2024-05-09 | 2024-03-31 | $-3.20 | $-3.20 |
| 2024-02-29 | 2023-12-31 | $-3.60 | $-3.60 |
| 2023-11-08 | 2023-09-30 | $-3.60 | $-3.60 |
| 2023-08-09 | 2023-06-30 | $-3.60 | $-3.60 |
| 2023-05-10 | 2023-03-31 | $-3.60 | $-3.20 |
| 2023-03-01 | 2022-12-31 | $-12.00 | $-1.60 |
| 2022-11-14 | 2022-09-30 | $-10.00 | $-16.00 |
| 2022-08-15 | 2022-06-30 | $-2.00 | $-16.40 |
| 2022-05-16 | 2022-03-31 | $-1.60 | $-2.00 |
| 2022-03-28 | 2021-12-31 | $-2.00 | $-0.40 |
| 2021-11-15 | 2021-09-30 | $-1.60 | $-2.80 |